Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Meng-Xia Zhang,Li Wang,Lei Zeng,Zi-Wei Tu

DOI: https://doi.org/10.3389/fonc.2021.670714

IF: 4.7

2021-03-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.605777.].

oncology

What problem does this paper attempt to address?

Lcn2 Is A Potential Biomarker For Radioresistance And Recurrence In Nasopharyngeal Carcinoma (Vol 10, 605777, 2021)

Meng-Xia Zhang,Li Wang,Lei Zeng,Zi-Wei Tu

DOI: https://doi.org/10.3389/fonc.2021.670714

IF: 4.7

2021-01-01

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.605777.].
Corrigendum: Association of preoperative NANOG-positive circulating tumor cell levels with recurrence of hepatocellular carcinoma

Yongrong Lei,Xishu Wang,Heng Sun,Yuna Fu,Yichen Tian,Ludi Yang,Jianhua Wang,Feng Xia

DOI: https://doi.org/10.3389/fonc.2024.1438731

2024-07-10

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.601668.].
Corrigendum: A novel LncRNA, AC091729.7 promotes sinonasal squamous cell carcinomas proliferation and invasion through binding SRSF2

Boyu Yu,Linmei Qu,Tianyi Wu,Bingrui Yan,Xuan Kan,Xuehui Zhao,Like Yang,Yushan Li,Ming Liu,Linli Tian,Yanan Sun,Qiuying Li

DOI: https://doi.org/10.3389/fonc.2024.1476128

2024-09-30

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.01575.].
Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Fang-Ze Wei,Shi-Wen Mei,Zhi-Jie Wang,Jia-Nan Chen,Hai-Yu Shen,Fu-Qiang Zhao,Juan Li,Zheng Liu,Qian Liu

DOI: https://doi.org/10.3389/fonc.2020.634122

IF: 4.7

2020-12-18

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.573295.].

oncology
Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Jun Cao,Mengdi Zhang,Bin Wang,Long Zhang,Fangfang Zhou,Meiyu Fang

DOI: https://doi.org/10.3389/fonc.2021.745052

IF: 4.7

2021-08-17

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.658552.].

oncology
Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling

Wen Yang,Zhikun Zheng,Pengfei Yi,Shi Wang,Ning Zhang,Jie Ming,Jie Tan,Hui Guo

DOI: https://doi.org/10.3389/fonc.2021.759471

IF: 4.7

2021-08-27

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.00956.].

oncology
Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma

Yun-Zhu Zeng,Yong-Qu Zhang,Jiong-Yu Chen,Li-Ying Zhang,Wen-Liang Gao,Xue-Qiong Lin,Shao-Min Huang,Fan Zhang,Xiao-Long Wei

DOI: https://doi.org/10.3389/fonc.2021.767805

IF: 4.7

2021-10-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.627713.].

oncology
Corrigendum: Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study

Min Yuan,Zhongzheng Zhu,Wei Mao,Hui Wang,Hong Qian,Jianguo Wu,Xianling Guo,Qing Xu

DOI: https://doi.org/10.3389/fonc.2021.796625

IF: 4.7

2022-01-04

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.683502.].

oncology
Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Wen-Jie Wu,Qian Liu,Pu-Gen An,Lin Wang,Jian-Yun Zhang,Yan Chen,Tong Zhang,Jie Zhang

DOI: https://doi.org/10.3389/fimmu.2023.1346845

IF: 7.3

2024-01-01

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2023.1282629.].
Corrigendum: Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinoma

Xi Chen,Jishu Guo,Fan Zhou,Wenjun Ren,Xiaobin Huang,Jun Pu,Xiaoqun Niu,Xiulin Jiang

DOI: https://doi.org/10.3389/fonc.2024.1223478

IF: 4.7

2024-09-04

Frontiers in Oncology

Abstract:This article is a correction to: Long Non-Coding RNA AL139385.1 as a Novel Prognostic Biomarker in Lung Adenocarcinoma

oncology
Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib

Lei Zhang,Zhi-Ping Yan,Zhong-Heng Hou,Peng Huang,Min-Jie Yang,Shuai Zhang,Shen Zhang,Shao-Hua Zhang,Xiao-Li Zhu,Cai-Fang Ni,Qiang Li

DOI: https://doi.org/10.3389/fmolb.2021.727969

IF: 6.113

2021-08-30

Frontiers in Molecular Biosciences

Abstract:[This corrects the article DOI: 10.3389/fmolb.2021.624366.].

biochemistry & molecular biology
Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

TingAn Wang,HuaGe Zhong,YuZhou Qin,WeiYuan Wei,Zhao Li,MingWei Huang,XiaoLing Luo

DOI: https://doi.org/10.1155/2021/3179693

2021-02-09

BioMed Research International

Abstract:[This corrects the article DOI: 10.1155/2020/3575038.].

biotechnology & applied microbiology,medicine, research & experimental
Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Daling Dong,Shixin Zhang,Bin Jiang,Wei Wei,Chao Wang,Qian Yang,Tingzhi Yan,Min Chen,Liken Zheng,Weikang Shao,Gang Xiong

DOI: https://doi.org/10.3389/fonc.2023.1275851

IF: 4.7

2023-08-25

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2023.1222716.].

oncology
Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Si Liu,Honglan Zhou,Gang Wang,Xin Lian

DOI: https://doi.org/10.3389/fcell.2023.1216783

IF: 5.5

2023-06-01

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2021.709490.].

cell biology,developmental biology
Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Mingchuang Zhu,Qingpeng Zeng,Tao Fan,Yuanyuan Lei,Feng Wang,Sufei Zheng,Xinfeng Wang,Hui Zeng,Fengwei Tan,Nan Sun,Qi Xue,Jie He

DOI: https://doi.org/10.3389/fimmu.2022.909105

IF: 7.3

2022-05-04

Frontiers in Immunology

Abstract:[This corrects the article DOI: 10.3389/fimmu.2022.783495.].

immunology
Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Yicong Yao,Yi Wang,Denglong Wu,Baoying Hu

DOI: https://doi.org/10.3389/fonc.2021.731942

IF: 4.7

2021-07-21

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.666418.].

oncology
Corrigendum: Effect of Carbon Ion Radiation Induce Bystander Effect on Metastasis of A549 Cells and Metabonomic Correlation Analysis

Zhen Yang,Qiuning Zhang,Hongtao Luo,Lihua Shao,Ruifeng Liu,Yarong Kong,Xueshan Zhao,Yichao Geng,Chengcheng Li,Xiaohu Wang

DOI: https://doi.org/10.3389/fonc.2021.783377

IF: 4.7

2021-10-12

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2020.601620.].

oncology
Corrigendum: LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression

Kuanhou Mou,Xiang Zhang,Xin Mu,Rui Ge,Dan Han,Yan Zhou,Li-Juan Wang

DOI: https://doi.org/10.3389/fonc.2022.905360

IF: 4.7

2022-05-10

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00569.].

oncology
Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Fangling Cheng,Po Zhang,Qungen Xiao,Youwei Li,Minhai Dong,Heping Wang,Dong Kuang,Yue He,Qiuhong Duan,Feng Mao,Baofeng Wang,Dongsheng Guo

DOI: https://doi.org/10.3389/fonc.2020.591112

2020-09-25

Abstract:[This corrects the article DOI: 10.3389/fonc.2019.00447.].
Corrigendum: Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma

Fang Tong,Lifa Xu,Sheng Xu,Mingming Zhang

DOI: https://doi.org/10.3389/fgene.2022.1050296

IF: 3.7

2022-10-25

Frontiers in Genetics

Abstract:[This corrects the article DOI: 10.3389/fgene.2022.834935.].

genetics & heredity

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Lcn2 Is A Potential Biomarker For Radioresistance And Recurrence In Nasopharyngeal Carcinoma (Vol 10, 605777, 2021)

Corrigendum: Association of preoperative NANOG-positive circulating tumor cell levels with recurrence of hepatocellular carcinoma

Corrigendum: A novel LncRNA, AC091729.7 promotes sinonasal squamous cell carcinomas proliferation and invasion through binding SRSF2

Corrigendum: Differential Expression Analysis Revealing CLCA1 to Be a Prognostic and Diagnostic Biomarker for Colorectal Cancer

Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies

Corrigendum: LncRNA NBR2 Inhibits the Malignancy of Thyroid Cancer, Associated With Enhancing the AMPK Signaling

Corrigendum: TRPC1 Inhibits Cell Proliferation/Invasion and Is Predictive of a Better Prognosis of Esophageal Squamous Cell Carcinoma

Corrigendum: Anlotinib Combined With Anti-PD-1 Antibodies Therapy in Patients With Advanced Refractory Solid Tumors: A Single-Center, Observational, Prospective Study

Corrigendum: Neoadjuvant Tislelizumab Combined with Chemotherapy in Locally Advanced Oral or Oropharyngeal Squamous Cell Carcinoma: a Real-World Retrospective Study.

Corrigendum: Long non-coding RNA AL139385.1 as a novel prognostic biomarker in lung adenocarcinoma

Corrigendum: Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Predictors of Outcomes in Patients With Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization Plus Sorafenib

Corrigendum to “ARMCX Family Gene Expression Analysis and Potential Prognostic Biomarkers for Prediction of Clinical Outcome in Patients with Gastric Carcinoma”

Corrigendum: Correlation analysis of MRD positivity in patients with completely resected stage I-IIIA non-small cell lung cancer: a cohort study

Corrigendum: Comprehensive transcriptomic analysis of critical RNA regulation associated with metabolism and prognosis in clear cell renal carcinoma

Corrigendum: Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis

Corrigendum: Increased CDC6 Expression Associates With Poor Prognosis in Patients With Clear Cell Renal Cell Carcinoma

Corrigendum: Effect of Carbon Ion Radiation Induce Bystander Effect on Metastasis of A549 Cells and Metabonomic Correlation Analysis

Corrigendum: LNMAT1 Promotes Invasion-Metastasis Cascade in Malignant Melanoma by Epigenetically Suppressing CADM1 Expression

Corrigendum: The Prognostic and Therapeutic Potential of LRIG3 and Soluble LRIG3 in Glioblastoma

Corrigendum: Identification of an autophagy-related 12-lncRNA signature and evaluation of NFYC-AS1 as a pro-cancer factor in lung adenocarcinoma